Salicylic acid: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|indicationType=treatment | |indicationType=treatment | ||
|indication=[[acne]], for relief of [[itching]], irritation, redness and scaling assoicated with [[psoriasis]], [[eczema]] and [[seborrheic dermatitis]] | |indication=[[acne]], for relief of [[itching]], irritation, redness and scaling assoicated with [[psoriasis]], [[eczema]] and [[seborrheic dermatitis]] | ||
|adverseReactions=hypersensitivity reaction, salicylate toxicity | |adverseReactions=[[hypersensitivity]] reaction, salicylate toxicity | ||
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | ||
Line 22: | Line 22: | ||
Disorder of skin, Hyperkeratotic: gel, apply TOPICALLY to the affected area and occlude the area at night. | Disorder of skin, Hyperkeratotic: gel, apply TOPICALLY to the affected area and occlude the area at night. | ||
* Disorder of skin, Hyperkeratotic | * Disorder of skin, Hyperkeratotic | ||
:* shampoo, wet hair and apply TOPICALLY to the scalp, work into a lather and rinse; repeat the treatment as needed until the condition clears | :* shampoo, wet hair and apply TOPICALLY to the scalp, work into a lather and rinse; repeat the treatment as needed until the condition clears [5] | ||
* Psoriasis | * Psoriasis | ||
:* Apply TOPICALLY in concentrations of 3% to 6% | :* Apply TOPICALLY in concentrations of 3% to 6% | ||
* Removal of wart | * Removal of wart | ||
:* Apply TOPICALLY once or twice daily in concentrations of 5% to 40% for up to 12 weeks | :* Apply TOPICALLY once or twice daily in concentrations of 5% to 40% for up to 12 weeks | ||
|offLabelAdultNoGuideSupport= | |offLabelAdultNoGuideSupport======Condition1===== | ||
* Dosing Information | |||
:* Dosage | |||
=====Condition2===== | |||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | ||
Line 35: | Line 40: | ||
<!--FDA-Labeled Indications and Dosage (Pediatric)--> | <!--FDA-Labeled Indications and Dosage (Pediatric)--> | ||
|fdaLIADPed= | |fdaLIADPed======Condition1===== | ||
* Dosing Information | |||
:* Dosage | |||
=====Condition2===== | |||
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | ||
Line 43: | Line 53: | ||
<!--Guideline-Supported Use (Pediatric)--> | <!--Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedGuideSupport= | |offLabelPedGuideSupport======Condition1===== | ||
* Developed by: | |||
* Class of Recommendation: | |||
* Strength of Evidence: | |||
* Dosing Information | |||
:* Dosage | |||
=====Condition2===== | |||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
<!--Non–Guideline-Supported Use (Pediatric)--> | <!--Non–Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedNoGuideSupport= | |offLabelPedNoGuideSupport======Condition1===== | ||
* Dosing Information | |||
:* Dosage | |||
=====Condition2===== | |||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
<!--Contraindications--> | <!--Contraindications--> | ||
|contraindications=* Condition1 | |||
<!--Warnings--> | |||
|warnings=* For external use only. | |warnings=* For external use only. | ||
* Avoid contact with eyes. If contact occurs, rinse thoroughly with water. | * Avoid contact with eyes. If contact occurs, rinse thoroughly with water. | ||
Line 57: | Line 90: | ||
* Do not use for prolonged periods without consulting a doctor. | * Do not use for prolonged periods without consulting a doctor. | ||
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | |clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | ||
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label. | |postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label. | ||
|useInPregnancyFDA=* '''Pregnancy Category''' | |useInPregnancyFDA=* '''Pregnancy Category''' | ||
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | ||
Line 76: | Line 113: | ||
|administration=* Oral | |administration=* Oral | ||
* Intravenous | |||
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | |monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | ||
* Description | |||
<!--IV Compatibility--> | <!--IV Compatibility--> | ||
Line 85: | Line 122: | ||
<!--Overdosage--> | <!--Overdosage--> | ||
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label. | |overdose====Acute Overdose=== | ||
====Signs and Symptoms==== | |||
* Description | |||
====Management==== | |||
* Description | |||
===Chronic Overdose=== | |||
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label. | |||
<!--Pharmacology--> | <!--Pharmacology--> | ||
<!--Drug box 2--> | <!--Drug box 2--> | ||
|drugBox= | |drugBox=<!--Mechanism of Action--> | ||
|mechAction=* | |||
|mechAction= | |||
<!--Structure--> | |||
|structure=* | |||
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]] | |||
<!--Pharmacodynamics--> | <!--Pharmacodynamics--> | ||
Line 188: | Line 168: | ||
<!--Brand Names--> | <!--Brand Names--> | ||
|brandNames=* ALA-SEPTIC®<ref>{{Cite web | title =ALA-SEPTIC- salicylic acid cream | url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=edb70750-bea8-4c0f-9453-f2c38d2f05d9 }}</ref> | |brandNames=* ALA-SEPTIC®<ref>{{Cite web | title =ALA-SEPTIC- salicylic acid cream | url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=edb70750-bea8-4c0f-9453-f2c38d2f05d9 }}</ref> | ||
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web | last = | first = | title = http://www.ismp.org | url = http://www.ismp.org | publisher = | date = }}</ref> | |lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web | last = | first = | title = http://www.ismp.org | url = http://www.ismp.org | publisher = | date = }}</ref> | ||
Revision as of 06:26, 17 December 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Salicylic acid is a anti acne agent that is FDA approved for the treatment of acne, for relief of itching, irritation, redness and scaling assoicated with psoriasis, eczema and seborrheic dermatitis. Common adverse reactions include hypersensitivity reaction, salicylate toxicity.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- FOR THE TREATMENT OF ACNE
- HELPS KEEP SKIN CLEAR OF NEW ACNE BLEMISHES
- For relief of itching, irritation, redness and scaling assoicated with psoriasis, eczema and seborrheic dermatitis.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
- Acne vulgaris
- Apply TOPICALLY in concentrations of 0.5% to 10%
Disorder of skin, Hyperkeratotic: gel, apply TOPICALLY to the affected area and occlude the area at night.
- Disorder of skin, Hyperkeratotic
- shampoo, wet hair and apply TOPICALLY to the scalp, work into a lather and rinse; repeat the treatment as needed until the condition clears [5]
- Psoriasis
- Apply TOPICALLY in concentrations of 3% to 6%
- Removal of wart
- Apply TOPICALLY once or twice daily in concentrations of 5% to 40% for up to 12 weeks
Non–Guideline-Supported Use
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Salicylic acid in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding FDA-Labeled Use of Salicylic acid in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
Condition1
- Developed by:
- Class of Recommendation:
- Strength of Evidence:
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Salicylic acid in pediatric patients.
Non–Guideline-Supported Use
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Salicylic acid in pediatric patients.
Contraindications
- Condition1
Warnings
- For external use only.
- Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
- Do not use without consulting a doctor if the condition appears over a large portion of hte body.
- If condition worsens, or does not improve after using as directed, consult physician.
- Do not use for prolonged periods without consulting a doctor.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Salicylic acid in the drug label.
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Salicylic acid in the drug label.
Drug Interactions
There is limited information regarding Salicylic acid Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Salicylic acid in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Salicylic acid during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Salicylic acid with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Salicylic acid with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Salicylic acid with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Salicylic acid with respect to specific gender populations.
Race
There is no FDA guidance on the use of Salicylic acid with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Salicylic acid in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Salicylic acid in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Salicylic acid in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Salicylic acid in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
- Intravenous
Monitoring
There is limited information regarding Monitoring of Salicylic acid in the drug label.
- Description
IV Compatibility
There is limited information regarding IV Compatibility of Salicylic acid in the drug label.
Overdosage
Acute Overdose
Signs and Symptoms
- Description
Management
- Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Salicylic acid in the drug label.
Pharmacology
There is limited information regarding Salicylic acid Pharmacology in the drug label.
Mechanism of Action
Structure
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Salicylic acid in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Salicylic acid in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Salicylic acid in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Salicylic acid in the drug label.
How Supplied
Storage
There is limited information regarding Salicylic acid Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Salicylic acid |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Salicylic acid |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
- Wash affected areas well with soap and water. Pat dry. Apply cream to affected area one to four times per day, or as directed by physician.
Precautions with Alcohol
- Alcohol-Salicylic acid interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ALA-SEPTIC®[1]
Look-Alike Drug Names
- A® — B®[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ "ALA-SEPTIC- salicylic acid cream".
- ↑ "http://www.ismp.org". External link in
|title=
(help)
{{#subobject:
|Label Page=Salicylic acid |Label Name=Saly 1.jpg
}}
{{#subobject:
|Label Page=Salicylic acid |Label Name=
}}